REGN News
Regeneron Pharmaceuticals, Inc.
$804.16
+$25.79(+3.31%)
59
Overall
80
Value
40
Tech
57
Quality
Market Cap
$80.14B
Volume
290.31K
52W Range
$541.00 - $859.34
Target Price
$861.62
REGN news: the latest Regeneron Pharmaceuticals, Inc. headlines, press releases and market updates, newest first.
Latest REGN News
- Bank of America Securities Sticks to Their Buy Rating for Regeneron (REGN)TipRanks Auto-Generated Intelligence Newsdesk · Oct 12, 2026
- Regeneron Advances Pediatric Rare Disease Program With New Phase 3 Garetosmab StudyTipRanks Clinical-Trials-Auto-Generated Newsdesk · Oct 8, 2026
- Analysts Offer Insights on Healthcare Companies: Cigna (CI), Wave Life Sciences (WVE) and Regeneron (REGN)TipRanks Newsroom · Oct 2, 2026
- Analysts’ Top Healthcare Picks: Regeneron (REGN), Idexx Laboratories (IDXX)TipRanks Newsroom · Oct 2, 2026
- Barclays Sticks to Its Buy Rating for Regeneron (REGN)TipRanks Auto-Generated Intelligence Newsdesk · Oct 2, 2026
- Jefferies Sticks to Their Buy Rating for Regeneron (REGN)TipRanks Auto-Generated Intelligence Newsdesk · Oct 1, 2026
- Real-World Dupixent Data in Itchy Skin Disease: What Sanofi and Regeneron Investors Should WatchTipRanks Clinical-Trials-Auto-Generated Newsdesk · Oct 1, 2026
- Regeneron (REGN) Receives a Hold from BernsteinTipRanks Auto-Generated Intelligence Newsdesk · Sep 26, 2026
- Analysts Are Bullish on Top Healthcare Stocks: Agilent (A), Regeneron (REGN)TipRanks Newsroom · Sep 26, 2026
- Regeneron Steps Into Obesity Drug Race With New Phase 1 StudyTipRanks Clinical-Trials-Auto-Generated Newsdesk · Sep 25, 2026
- RBC Capital Sticks to Their Hold Rating for Regeneron (REGN)TipRanks Auto-Generated Intelligence Newsdesk · Sep 24, 2026
- Itepekimab COPD Extension Trial Completion: What It Means for Regeneron and SanofiTipRanks Clinical-Trials-Auto-Generated Newsdesk · Sep 18, 2026
- Regeneron’s ROXI-EVEREST Trial Puts a New Stroke Drug in the SpotlightTipRanks Clinical-Trials-Auto-Generated Newsdesk · Sep 16, 2026
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | REGN | $804.16 | +3.3% | 290.31K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Regeneron Pharmaceuticals, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW